Welsh Briana, Chao Michael, Foroudi Farshad
Radiation Oncology, Olivia Newton-John Cancer & Wellness Centre, Austin Health, Heidelberg, Victoria, Australia.
J Med Radiat Sci. 2017 Jun;64(2):114-119. doi: 10.1002/jmrs.191. Epub 2016 Sep 9.
When irradiating the left breast, a small portion of the heart and left anterior descending coronary artery (LAD) are often included in the treatment field. Deep inspiration breath-hold (DIBH) techniques reduce dose to coronary structures, but are resource intensive and may not be tolerated by all patients. The aim of this study was to evaluate a simple multi-leaf collimator (MLC) modification technique with respect to target coverage and organ-at-risk sparing.
Forty nine patients with left-sided breast cancer, planned with a simultaneous integrated boost technique were retrospectively replanned with additional shielding of the LAD. Dose to the target volumes (whole breast and boost) and organs at risk (heart, ipsilateral lung and LAD) were assessed on both plans.
Significant dose reductions were observed for all organs at risk when LAD shielding was introduced, with a reduction in mean LAD dose of 7.0 Gy, mean LAD planning risk volume (PRV) dose of 5.9 Gy, maximum LAD dose of 12 Gy and mean heart dose of 0.73 Gy. Target volume coverage was clinically acceptable for 96% of patients, using the left anterior descending coronary artery shielded plan (LADSP). No difference was observed between the standard plan (SP) and LADSP in nine patients (18%).
For selected patients, the implementation of a simple MLC shielding technique can reduce the dose to cardiac structures, whilst maintaining breast and boost volume dosimetry. This technique is simple to implement and may be used as an alternative to DIBH for those patients who are unable to fulfill the selection criteria, or departments who are not resourced to perform DIBH.
在对左侧乳房进行放射治疗时,心脏的一小部分和左前降支冠状动脉(LAD)通常会被纳入治疗野。深吸气屏气(DIBH)技术可降低冠状动脉结构的剂量,但资源消耗大,且并非所有患者都能耐受。本研究的目的是评估一种简单的多叶准直器(MLC)改良技术在靶区覆盖和危及器官保护方面的效果。
对49例采用同步整合加量技术计划治疗的左侧乳腺癌患者进行回顾性重新计划,增加对LAD的屏蔽。在两个计划中评估靶区体积(全乳和加量区)和危及器官(心脏、同侧肺和LAD)的剂量。
引入LAD屏蔽后,所有危及器官的剂量均显著降低,LAD平均剂量降低7.0 Gy,LAD计划风险体积(PRV)平均剂量降低5.9 Gy,LAD最大剂量降低12 Gy,心脏平均剂量降低0.73 Gy。使用左前降支冠状动脉屏蔽计划(LADSP)时,96%的患者靶区体积覆盖在临床可接受范围内。9例患者(18%)的标准计划(SP)和LADSP之间未观察到差异。
对于选定的患者,实施简单的MLC屏蔽技术可降低心脏结构的剂量,同时保持乳房和加量区的剂量测定。该技术易于实施,可作为无法满足选择标准的患者或没有资源进行DIBH的科室的DIBH替代方法。